ENRIGHT PATRICK G

Average Profitability
18.91%
Insider Buys Quantity
11
Insider Buys Sum
$88.22M
Insider Sells Quantity
75
Insider Sells Sum
$677.12M

Insider Activity of ENRIGHT PATRICK G

The largest purchase of all time was on 2021-05-18 and amounted to 1818180 shares of Vera Therapeutics, Inc. for $20M.

The largest sale of all time was on 2014-02-28 and amounted to 1095734 shares of Jazz Pharmaceuticals plc for $167.01M.

Biography of ENRIGHT PATRICK G

No biography is available at this moment.

2023-08-14SaleJazz Pharmaceuticals plc
JAZZ
director
1,241
0.0019%
$138.16$171,455-13.48%
2023-02-06PurchaseVera Therapeutics, Inc.
VERA
1.71M
4.5707%
$7.00$12M+91.54%
2022-11-22SaleJazz Pharmaceuticals plc
JAZZ
director
6,974
0.0109%
$150.45$1.05M-10.74%
2022-08-05SaleJazz Pharmaceuticals plc
JAZZ
1,089
0.0017%
$152.33$165,883-6.46%
2022-04-19PurchaseInozyme Pharma, Inc.
INZY
1.35M
2.811%
$3.69$5M-33.04%
2022-02-10PurchaseVera Therapeutics, Inc.
VERA
666,666
2.3189%
$15.00$10M+3.03%
2021-05-18PurchaseVera Therapeutics, Inc.
VERA
1.82M
15.4233%
$11.00$20M+57.41%
2020-11-12SaleJazz Pharmaceuticals plc
JAZZ
director
9,929
0.018%
$146.72$1.46M+11.79%
2019-08-09SaleJazz Pharmaceuticals plc
JAZZ
director
726
0.0013%
$135.65$98,481-9.37%
2018-09-06SaleJazz Pharmaceuticals plc
JAZZ
director
10,130
0.0167%
$168.76$1.71M-19.03%
2018-08-10SaleJazz Pharmaceuticals plc
JAZZ
director
1,365
0.0022%
$175.13$239,057-21.48%
2017-12-11SaleJazz Pharmaceuticals plc
JAZZ
director
9,000
0.015%
$139.73$1.26M+11.43%
2017-11-17SaleJazz Pharmaceuticals plc
JAZZ
director
352
0.0006%
$133.19$46,883+16.53%
2017-08-25SaleJazz Pharmaceuticals plc
JAZZ
director
351
0.0006%
$148.40$52,088+2.68%
2017-08-11SaleJazz Pharmaceuticals plc
JAZZ
director
662
0.0011%
$142.37$94,248+4.2%
2017-03-16SaleCorcept Therapeutics Incorporated
CORT
director
269,955
0.2406%
$9.94$2.68M+57.39%
2017-03-15SaleCorcept Therapeutics Incorporated
CORT
director
279,020
0.2479%
$10.24$2.86M+51.71%
2017-03-14SaleCorcept Therapeutics Incorporated
CORT
director
300,000
0.2679%
$10.01$3M+55.14%
2017-03-13SaleCorcept Therapeutics Incorporated
CORT
director
20,980
0.0192%
$11.13$233,491+42.62%
2017-03-08SaleCorcept Therapeutics Incorporated
CORT
director
750,000
0.6665%
$9.75$7.31M+55.81%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.